77% of Pharma Manufacturers likely to recommend Videojet
An independent survey carried out with over 2000 professionals in the Pharmaceutical and Medical industry identifies where manufacturers are positioned on the road to implementing serialization.
See what they had to say.
58% of all sites have lines impacted by FMD
(Falsified Medicines Directive) or DSCSA
(Drug Supply Chain Security Act)
All have one line impacted, 10% have more than 15
Nearly half the lines (48%) are yet to be ‘Serialization Ready
75% of lines impacted by legislation see approximately half the product being placed in a carton.
At least 75% of lines impacted by serialization require product to be bundle wrapped for aggregation.
For 66% of the lines that are not ‘Serialization Ready’…
66% of the lines that are not ‘Serialization Ready’ no action is planned for the next 12 months!
69% will be looking for a standard serialization approach across all lines
60% of responders will acquire their Serialization Printer direct from the printer manufacturer, another 26% will get theirs from a Serialization integrator
77% of Pharma Manufacturers likely to
recommend Videojet
Meeting future compliance needs
White paper on pharmaceutical packaging serialization
Thermal inkjet solutions for global track and trace
*Independent Research conducted by TechValidate Survey 8th September 2015 TVID: 7F9 8DB 2C5
